Stock listing
Stockholm:GABA Gabather AB Aktie
Home listing (Stockholm) of Gabather AB
Follow Gabather AB into a list and get an email when it puts out news.
Share price · OMXSTO:GABA
0.015 SEK -0.003 (-16.3%)
Close on Nov 20, 2026
Past year -48.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits- Day range
- 0.012 – 0.019 SEKNov 20, 2026
- Volume
- 8.50M sharesNov 20, 2026
- Market cap
- 9.40M SEKAt the close on Nov 20, 2026 · price × 610.5M shares outstanding
- 52-week range
- 0.012 – 0.100 SEKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 62,360 SEKMedian day 1.80M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|
| Stockholm:GABA · Home | 0.015 SEK | -0.003 (-16.3%) | 8,496,202 | 0.019 | 0.019 | 0.012 | 0.018 | Close on Nov 20, 2026 |
|---|
| Frankfurt:5J2 | €0.0050 EUR | +0.0030 (+150.0%) | — | — | €0.0050 | — | €0.0020 | Close on Oct 27, 2026 |
|---|
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXSTO:GABA · SEK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|
| 0.015 | -0.003 | -16.3% | 0.019 | 0.019 | 0.012 | 8,496,202 |
|---|
| 0.018 | +0.000 | +2.2% | 0.018 | 0.018 | 0.017 | 163,884 |
|---|
| 0.018 | -0.002 | -8.2% | 0.019 | 0.019 | 0.017 | 1,097,209 |
|---|
| 0.020 | +0.001 | +7.7% | 0.016 | 0.020 | 0.016 | 2,992,208 |
|---|
| 0.018 | -0.001 | -3.2% | 0.019 | 0.019 | 0.016 | 1,834,794 |
|---|
| 0.019 | -0.001 | -6.0% | 0.020 | 0.020 | 0.017 | 1,808,693 |
|---|
| 0.020 | -0.001 | -2.9% | 0.021 | 0.021 | 0.018 | 502,928 |
|---|
| 0.021 | +0.001 | +7.3% | 0.018 | 0.021 | 0.017 | 4,181,673 |
|---|
| 0.019 | 0.000 | -1.0% | 0.019 | 0.019 | 0.018 | 1,348,052 |
|---|
| 0.019 | -0.001 | -3.0% | 0.020 | 0.020 | 0.018 | 1,024,033 |
|---|
| 0.020 | 0.000 | 0.0% | 0.020 | 0.020 | 0.018 | 2,278,875 |
|---|
| 0.020 | 0.000 | 0.0% | 0.020 | 0.021 | 0.019 | 1,583,088 |
|---|
| 0.020 | +0.002 | +9.9% | 0.020 | 0.025 | 0.019 | 11,584,259 |
|---|
| 0.018 | -0.001 | -7.1% | 0.018 | 0.019 | 0.018 | 813,169 |
|---|
| 0.020 | 0.000 | -1.0% | 0.019 | 0.020 | 0.018 | 3,931,480 |
|---|
| 0.020 | -0.001 | -2.9% | 0.020 | 0.021 | 0.020 | 467,271 |
|---|
| 0.020 | -0.001 | -2.9% | 0.020 | 0.020 | 0.019 | 3,020,977 |
|---|
| 0.021 | -0.002 | -7.1% | 0.023 | 0.023 | 0.019 | 3,931,027 |
|---|
| 0.023 | +0.001 | +2.7% | 0.021 | 0.023 | 0.018 | 3,778,040 |
|---|
| 0.022 | -0.001 | -2.7% | 0.024 | 0.024 | 0.021 | 3,153,995 |
|---|
| 0.023 | +0.002 | +8.7% | 0.021 | 0.026 | 0.021 | 5,582,793 |
|---|
| 0.021 | -0.001 | -5.5% | 0.022 | 0.022 | 0.020 | 1,972,941 |
|---|
| 0.022 | -0.002 | -6.8% | 0.024 | 0.024 | 0.021 | 2,922,652 |
|---|
| 0.024 | 0.000 | -1.7% | 0.024 | 0.024 | 0.022 | 2,593,778 |
|---|
| 0.024 | -0.002 | -7.7% | 0.025 | 0.026 | 0.020 | 4,605,189 |
|---|
| 0.026 | +0.001 | +4.0% | 0.024 | 0.028 | 0.024 | 1,443,470 |
|---|
| 0.025 | +0.001 | +4.2% | 0.024 | 0.025 | 0.023 | 1,331,031 |
|---|
| 0.024 | 0.000 | -1.6% | 0.023 | 0.024 | 0.023 | 309,655 |
|---|
| 0.024 | 0.000 | -0.8% | 0.023 | 0.025 | 0.023 | 325,041 |
|---|
| 0.025 | -0.001 | -3.9% | 0.026 | 0.026 | 0.023 | 618,117 |
|---|
| 0.026 | +0.001 | +2.4% | 0.026 | 0.026 | 0.023 | 1,795,698 |
|---|
| 0.025 | -0.001 | -3.1% | 0.025 | 0.026 | 0.025 | 1,512,155 |
|---|
| 0.026 | 0.000 | -1.5% | 0.026 | 0.028 | 0.025 | 4,692,816 |
|---|
| 0.026 | -0.002 | -6.4% | 0.026 | 0.028 | 0.026 | 578,082 |
|---|
| 0.028 | +0.001 | +5.3% | 0.027 | 0.030 | 0.025 | 3,298,395 |
|---|
| 0.027 | +0.001 | +3.9% | 0.026 | 0.027 | 0.025 | 967,393 |
|---|
| 0.026 | -0.002 | -5.9% | 0.027 | 0.027 | 0.025 | 1,840,994 |
|---|
| 0.027 | +0.002 | +7.9% | 0.027 | 0.028 | 0.025 | 1,317,751 |
|---|
| 0.025 | -0.003 | -10.6% | 0.025 | 0.034 | 0.025 | 5,788,710 |
|---|
| 0.028 | 0.000 | -0.7% | 0.026 | 0.028 | 0.024 | 1,149,413 |
|---|
| 0.028 | +0.000 | +0.7% | 0.026 | 0.028 | 0.026 | 351,605 |
|---|
| 0.028 | 0.000 | -1.4% | 0.026 | 0.029 | 0.026 | 692,727 |
|---|
| 0.029 | +0.002 | +6.7% | 0.027 | 0.029 | 0.026 | 2,474,363 |
|---|
| 0.027 | +0.000 | +0.8% | 0.027 | 0.027 | 0.025 | 1,332,452 |
|---|
| 0.027 | -0.001 | -2.9% | 0.028 | 0.028 | 0.025 | 1,045,106 |
|---|
| 0.027 | -0.003 | -8.7% | 0.030 | 0.030 | 0.026 | 2,835,540 |
|---|
| 0.030 | 0.000 | -0.7% | 0.030 | 0.030 | 0.028 | 596,598 |
|---|
| 0.030 | +0.000 | +1.3% | 0.030 | 0.030 | 0.029 | 316,407 |
|---|
| 0.030 | 0.000 | -0.7% | 0.030 | 0.030 | 0.027 | 1,837,604 |
|---|
| 0.030 | +0.001 | +3.4% | 0.031 | 0.031 | 0.029 | 733,916 |
|---|
| 0.029 | -0.002 | -6.5% | 0.031 | 0.031 | 0.028 | 2,831,959 |
|---|
| 0.031 | 0.000 | 0.0% | 0.031 | 0.032 | 0.028 | 873,483 |
|---|
| 0.031 | -0.001 | -2.5% | 0.032 | 0.032 | 0.030 | 1,182,116 |
|---|
| 0.032 | +0.001 | +4.6% | 0.030 | 0.032 | 0.030 | 744,962 |
|---|
| 0.030 | +0.001 | +4.8% | 0.029 | 0.030 | 0.029 | 691,200 |
|---|
| 0.029 | -0.007 | -19.4% | 0.038 | 0.038 | 0.028 | 8,699,790 |
|---|
| 0.036 | +0.002 | +5.3% | 0.032 | 0.039 | 0.029 | 11,127,995 |
|---|
| 0.034 | +0.000 | +1.2% | 0.034 | 0.034 | 0.032 | 3,119,266 |
|---|
| 0.034 | -0.001 | -2.9% | 0.035 | 0.035 | 0.031 | 5,594,904 |
|---|
| 0.035 | +0.004 | +13.0% | 0.031 | 0.036 | 0.031 | 3,176,265 |
|---|
| 0.031 | 0.000 | 0.0% | 0.032 | 0.032 | 0.031 | 111,677 |
|---|
| 0.031 | -0.001 | -3.7% | 0.032 | 0.032 | 0.031 | 1,906,007 |
|---|
| 0.032 | +0.000 | +1.3% | 0.031 | 0.032 | 0.030 | 343,710 |
|---|
| 0.032 | -0.001 | -3.7% | 0.033 | 0.033 | 0.030 | 2,781,064 |
|---|
Splits
1 split · OMXSTO:GABA · every price before a split is adjusted for it
| Day | Ratio | What |
|---|
| 1-for-4 | Consolidation |
|---|
- Ticker
- Stockholm:GABA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Stockholm
- Currency
- SEK
Gabather AB on 6ix
- News releases
- 1 in all · newest Jan 13, 2025 · oldest 2025
- Decks
- 2 decks · latest Dec 18, 2023
Where Gabather AB is listed
Valuation
Price/book 6.4× against a median of 0.3×: the highest of 11 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- 5.72M SEK
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- Negative EBITDA
- Price/book
- 6.4×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|
| Gabather AB · OMXSTO:GABA | US$922,076 | US$560,663 | n/a | n/a | n/a | 6.4× | n/a | 0.0× | n/a |
|---|
| Artelo Biosciences, Inc. · NASDAQ:ARTL | US$1.30M | US$1.34M | n/a | n/a | n/a | 0.2× | n/a | 0.0× | 1.36 |
|---|
| International Stem Cell Corporation · OTC:ISCO | US$1.28M | −US$18.76M | 0.1× | −2.0× | n/a | 0.1× | 222.6% | 0.0× | -0.52 |
|---|
| SureNano Science Ltd · CSE:SURE | US$1.17M | US$672,321 | n/a | n/a | n/a | 0.3× | n/a | 0.0× | 0.25 |
|---|
| Valion Bio, Inc. · NASDAQ:VBIO | US$1.04M | US$16.34M | n/a | 42.8× | n/a | 0.2× | n/a | 4.1× | 1.11 |
|---|
| GeoVax Labs, Inc. · NASDAQ:GOVX | US$985,460 | −US$915,033 | n/a | n/a | n/a | 0.9× | n/a | 0.2× | 1.47 |
|---|
| Biodexa Pharmaceuticals plc · NASDAQ:BDRX | US$982,950 | −US$3.22M | n/a | n/a | n/a | 0.1× | n/a | 0.0× | 1.01 |
|---|
| ExpreS2ion Biotech Holding AB · OMXSTO:EXPRS2 | US$794,844 | −US$2.43M | n/a | −6.5× | n/a | 0.2× | −935.9% | 0.0× | n/a |
|---|
| Silexion Therapeutics Corp · NASDAQ:SLXN | US$790,001 | −US$3.60M | n/a | n/a | n/a | 0.3× | n/a | 0.1× | 2.77 |
|---|
| Oragenics Inc. · AMEX:OGEN | US$708,377 | −US$1.12M | n/a | n/a | n/a | 0.7× | n/a | 0.4× | 1.47 |
|---|
| Protagenic Therapeutics, Inc. · OTC:PTIX | US$687,879 | US$610,970 | 0.1× | n/a | n/a | 0.6× | n/a | 0.0× | 1.21 |
|---|
| Median of the others | US$984,205 | −US$1.02M | 0.1× | −2.0× | | 0.3× | −356.6% | 0.0× | 1.21 |
|---|
Team and board
Board
| Director | Role |
|---|
| Bert Junno | Board member |
|---|
| Michael-Robin Witt | CEO & CSO |
|---|
| Theresa Comiskey Olsen | Board member |
|---|
Events
| Quarter | Results | Share move |
|---|
| Q2 2026 | Aug 27, 2026 | −1.7% |
|---|
| Q1 2026 | May 28, 2026 | −6.5% |
|---|
| Q4 2025 | Feb 26, 2026 | +33.3% |
|---|
| Q3 2025 | Nov 27, 2025 | +9.3% |
|---|
| Q2 2025 | Aug 28, 2025 | −13.7% |
|---|
| Q1 2025 | May 28, 2025 | −16.3% |
|---|
| Q1 2024 | Jun 28, 2024 · After close | +1.0% |
|---|
Open Events
Financials
Annual, in SEK
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|
| Revenue | 0 | 0 | 0 | 0 | -23.0K | 0 | 370 | 45.9K | 3.01M | 476.3K |
|---|
| Cost of revenue | | | | | | | 84.2K | 84.2K | 65.3K | 59.1K |
|---|
| Gross profit | | | | | | | -84.2K | -84.2K | -65.3K | -59.1K |
|---|
| Selling, general and administrative | 2.09M | 3.80M | 4.14M | 4.52M | 12.4M | 8.03M | 6.64M | 13.1M | 6.97M | 3.96M |
|---|
| Operating income | -4.53M | -7.78M | -9.47M | -8.55M | -17.0M | -14.6M | -14.3M | -20.3M | -9.94M | -7.89M |
|---|
| Depreciation and amortization | 0 | 7.78M | 9.47M | 8.55M | 84.0K | 84.0K | 84.2K | 84.2K | 65.3K | 59.1K |
|---|
| EBITDA | -4.53M | 0 | 0 | 0 | -16.9M | -14.6M | -14.2M | -20.2M | -9.87M | -7.84M |
|---|
| Interest expense | 155.0K | 0 | | 3.00K | 4.00K | 7.00K | 7.36K | 25.1K | 579 | 216 |
|---|
| Income before tax | -4.65M | -7.75M | -9.44M | -8.55M | -17.0M | -14.9M | -14.3M | -20.3M | -9.94M | -7.89M |
|---|
| Income tax | | | 9.47M | -3.00K | 4.00K | -115.0K | 7.36K | 25.1K | 579 | -320 |
|---|
| Net income | -4.65M | -7.75M | -9.44M | -8.54M | -17.0M | -14.9M | -14.3M | -20.3M | -9.94M | -7.89M |
|---|
| Earnings per share, basic | -0.02 | -0.37 | -0.65 | -0.63 | -1.27 | -1.12 | -2.22 | -3.94 | -2.69 | -2.16 |
|---|
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|
| Cash and equivalents | 3.14M | 878.0K | 1.11M | 6.27M | 14.8M | 30.9M | 44.9M | 16.6M | 36.7M | 27.9M |
|---|
| Receivables | 637.0K | 800.0K | 1.77M | 430.0K | 495.0K | 256.0K | 388.9K | 720.2K | 1.02M | 173.3K |
|---|
| Inventory | | | -1.77K | -430 | -495 | -256 | -388 | -720.2K | -974.7K | -27.9M |
|---|
| Current assets | 3.78M | 1.78M | 2.89M | 6.70M | 15.3M | 31.2M | 45.3M | 17.4M | 37.8M | 28.3M |
|---|
| Total assets | 3.83M | 1.83M | 7.36M | 6.75M | 15.4M | 32.2M | 46.1M | 18.2M | 48.2M | 34.7M |
|---|
| Accounts payable | 1.20M | 766.0K | 548.0K | 183.0K | 532.0K | 552.0K | 261.0K | 453.8K | 953.0K | 592.1K |
|---|
| Current liabilities | 4.69M | 6.01M | 6.88M | 3.31M | 4.43M | 3.31M | 2.48M | 2.29M | 2.42M | 1.56M |
|---|
| Total liabilities | 4.69M | 6.01M | 6.88M | 3.31M | 4.43M | 3.31M | 2.48M | 2.29M | 2.42M | 1.56M |
|---|
| Shareholders' equity | -863.0K | -4.17M | 486.0K | 3.44M | 11.0M | 27.9M | 43.6M | 15.9M | 45.8M | 33.2M |
|---|
| Shares outstanding | 192.2M | 20.7M | 14.5M | 13.6M | 13.4M | 13.4M | 6.44M | 5.16M | 3.70M | 3.65M |
|---|
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|
| Cash from operations | -7.22M | -3.33M | -11.6M | -9.60M | -16.1M | -13.7M | -13.7M | -20.1M | -9.68M | -7.09M |
|---|
| Capital spending | 0 | 0 | 0 | 0 | -345.0K | -289.0K | -73.9K | -43.9K | -4.03M | -3.35M |
|---|
| Free cash flow | -7.22M | -3.33M | -11.6M | -9.60M | -16.1M | -14.0M | -13.8M | -20.1M | -13.7M | -10.4M |
|---|
| Cash from investing | | | | | | -289.0K | -73.9K | -43.9K | -4.03M | -3.35M |
|---|
| Cash from financing | 9.49M | 3.09M | 6.49M | 1.02M | 46.0K | 46.0K | 42.0M | 42.2M | 22.5M | 28.3M |
|---|
| Share buybacks | 9.49M | 3.09M | 6.49M | 1.02M | 46.0K | 0 | 42.0M | 0 | 22.5M | 28.3M |
|---|
| Change in cash | 2.27M | -237.0K | -5.16M | -8.57M | -16.1M | -14.0M | 28.2M | -20.1M | 8.81M | 17.9M |
|---|
Open Financials
Cap table
Built by 6ix from Gabather AB’s releases
- Common shares
- 610,491,290
- Fully diluted
- 610,491,290
Fully diluted
| Line | Shares |
|---|
| Common shares | 610,491,290 |
|---|
Share count over time
| Count | Shares |
|---|
| Nov 22, 2026 | 610,491,290 |
|---|
Open Cap table
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|
| Bert Junno | Board member · Since at least Nov 4, 2026 |
|---|
| Christine Ryan | COO · Since at least Nov 5, 2026 |
|---|
| Michael-Robin Witt | CEO & CSO · Since at least Jan 13, 2025 |
|---|
| Theresa Comiskey Olsen | Board member · Since at least Nov 5, 2026 |
|---|
Open People
Log in to ask 6ix AI your own questions about Gabather AB.